Alcon

Alcon, a leader in the medical, precision, and optical instruments industry headquartered in Switzerland, is actively addressing its carbon footprint. In 2025, the company reported total emissions of approximately 1.38 billion kg CO2e. This figure comprises Scope 1 emissions of about 78.2 million kg CO2e, Scope 2 emissions (market-based) of approximately 122 million kg CO2e, and Scope 3 emissions totalling around 1.2 billion kg CO2e. The majority of these Scope 3 emissions are attributed to upstream transportation and distribution, accounting for approximately 1.15 billion kg CO2e.

Alcon has set ambitious climate commitments. By 2030, the company aims to achieve carbon neutrality across its global operations, covering Scope 1 and Scope 2 emissions. Furthermore, Alcon aspires to establish emissions targets for both 2040 and 2050, aligning with Swiss Climate Goals. While working towards defining a specific reduction target for Scope 3 emissions, Alcon's short-term focus is on refining its emissions data for priority categories, specifically purchased goods and services, along with upstream transportation and distribution. The company is developing a roadmap and action plan for the decarbonisation of its Scope 3 emissions.